论文部分内容阅读
[目的]观察三蛇汤辨证论治配合化疗治疗晚期肺癌的近期疗效。[方法]86例晚期非小细胞肺癌患者随机分为治疗组和对照组,其中治疗组44例,对照组42例;两组均予TP或GP,或NP小剂量静脉化疗,对照组单纯化疗,治疗组采用化疗合并中药三蛇汤治疗。[结果]治疗组和对照组中位生存期分别是12个月和10.5个月,平均生存期分别是13.61个月和12.14个月;1年生存率分别为47.73%和30.95%,2年生存率分别为13.64%和7.14%;治疗组和对照组的生活质量提高+稳定例数分别为41例和26例。[结论]三蛇汤对提高晚期非小细胞肺癌患者的生存质量具有重要意义,可能对延长晚期非小细胞肺癌患者生存期有一定作用。
[Objective] To observe the short-term curative effect of San She Tang syndrome differentiation and chemotherapy combined with chemotherapy on advanced lung cancer. [Methods] Eighty-six patients with advanced non-small cell lung cancer were randomly divided into treatment group and control group, 44 in the treatment group and 42 in the control group. Both groups received either TP or GP or NP low-dose intravenous chemotherapy. In the control group, chemotherapy alone , The treatment group using chemotherapy combined with three Snake soup treatment. [Results] The median survival time of the treatment group and the control group were 12 months and 10.5 months, respectively. The average survival time was 13.61 months and 12.14 months respectively. The 1-year survival rates were 47.73% and 30.95% respectively, and the 2-year survival rate The rates were 13.64% and 7.14% respectively. The quality of life improvement and stability in treatment group and control group were 41 cases and 26 cases respectively. [Conclusion] San snake soup is of great significance for improving the quality of life of patients with advanced non-small cell lung cancer and may play a role in prolonging the survival of patients with advanced non-small cell lung cancer.